US Patent Issued to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE DE MONTPELLIER, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) on Aug. 12 for "Methods for the diagnosis and treatment of gastrointestinal stromal tumors" (French Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,385,921, issued on Aug. 12, was assigned to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris), UNIVERSITE DE MONTPELLIER (Montpellier, France) and CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (Paris).

"Methods for the diagnosis and treatment of gastrointestinal stromal tumors" was invented by Pascal De Santa Barbara (Montpellier, France) and Sandrine Faure-De Santa Barbara (Montpellier, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the diagnosis of gastrointestinal stromal tumors (GISTs). The present invention also relates to methods and compositions for the treatment of gastrointe...